The science of skin aging is evolving rapidly — and for women navigating the skin changes that come with menopause and beyond, evidence-based skincare represents a fundamentally different approach: working with your skin's biology rather than against it.
Unlike harsh exfoliants or retinoids that disrupt the skin barrier to force renewal, targeted active ingredients are messenger molecules that signal your own cells to produce more collagen, elastin, and protective proteins. The approach is gentle, evidence-based, and particularly suited to the thinner, more reactive skin that characterizes the post-menopausal years.
Understanding the Two Structural Collagens That Define Skin Quality
The human dermis contains multiple collagen types, but two predominate: Type I collagen (approximately 80% of dermal collagen) and Type III collagen (approximately 15-20%). These two types serve different mechanical functions, are produced through overlapping but distinct pathways, and change at different rates with aging — making the distinction between them clinically relevant for anti-aging treatment. Type I collagen forms thick, densely packed fiber bundles that provide the dermis with tensile strength — the resistance to stretching and tearing that keeps skin structurally intact. Type III collagen forms thinner, more loosely organized fibers that provide flexibility, pliability, and the ability to deform under stress and recover. Together, they create a composite material that is both strong (Type I) and flexible (Type III) — the combination that defines healthy, youthful skin.[1]
How aging changes the Type I/Type III ratio: in young skin (under 30), the Type I to Type III ratio is approximately 4:1 — 80% Type I, 20% Type III. This ratio produces skin that is simultaneously firm and supple. With aging, both types decline in total quantity, but Type III declines faster than Type I, shifting the ratio toward higher Type I proportion. By age 60, the ratio may be 6:1 or higher — less Type III relative to Type I. The practical consequence: the skin becomes proportionally more rigid and less flexible. The suppleness and pliability that characterize youthful skin depend on adequate Type III collagen to provide the flexible component of the composite structure. Interestingly, wound healing reverses this ratio temporarily — fresh scar tissue is predominantly Type III collagen (soft, pliable) which is gradually remodeled into Type I collagen (strong, rigid) over 6-18 months. This wound healing sequence partially explains why skin repair treatments (microneedling, lasers) can temporarily restore some youthful skin qualities — they initiate a wound healing response that deposits fresh Type III collagen.
Clinical research confirms that treatment implications for Type I vs Type III: the good news is that the most effective topical collagen stimulators — retinoids and peptides — stimulate both Type I and Type III collagen production. Retinol activates procollagen I AND procollagen III gene expression through RAR/RXR receptor signaling. Peptides (Matrixyl 3000) stimulate both types through TGF-beta signaling. Vitamin C is required as a cofactor for the hydroxylation and cross-linking of both types. This means that a standard collagen-building routine (retinol + peptides + vitamin C) addresses both collagen types without requiring specialized products. However, the proportional response differs: fibroblast stimulation at any age produces proportionally more Type I than Type III collagen, reflecting the natural bias of adult collagen synthesis toward the dominant structural type.
What about collagen supplements — Type I vs Type III: oral collagen supplements are available as Type I (typically marine collagen from fish), Type III (typically bovine collagen from cattle), or a combination. The distinction matters less than marketing suggests, because the collagen is hydrolyzed into small peptide fragments (2-10 amino acids) during manufacturing and further during digestion. These peptide fragments — particularly prolyl-hydroxyproline and hydroxyprolyl-glycine — are the same regardless of whether they came from Type I or Type III collagen. The fibroblast response to these peptide fragments includes increased production of both Type I and Type III collagen, plus hyaluronic acid and fibrillin-1. The practical conclusion: choose a collagen supplement based on source preference (marine vs bovine) and molecular weight (2,000-5,000 Daltons for optimal bioavailability), not based on Type I vs Type III labeling. Both produce the same bioactive peptides after digestion. For topical treatment, the dual-type stimulation provided by retinol + peptides + vitamin C is the most effective approach for both collagen types simultaneously.
Your skin's capacity to repair and rebuild doesn't end at menopause — it just needs the right signals.
— Dr. Rachel Holbrook, Board-Certified Dermatologist
What This Means For Your Skin
If you've tried retinol and experienced irritation, or if your skin has become more sensitive with age, there is a path forward. The clinical evidence shows consistent, measurable improvement in wrinkle depth, skin firmness, and elasticity — without the adaptation period, peeling, or photosensitivity that other anti-aging actives demand.
Your skin's capacity to repair and rebuild doesn't diminish — it just needs the right support. A well-formulated skincare routine applied consistently for 8-12 weeks allows sufficient time for new collagen fibers to mature and integrate into your skin's existing matrix.
The science is clear. The evidence is consistent. The results are measurable.
What happens next is up to you.